Skip to main content
Simon Harms

Simon Harms, a Senior Associate in the firm’s Antitrust Litigation & Competition Regulation Group, advises clients on all aspects of UK and EU competition law, including UK / EU behavioural antitrust issues and worldwide merger control reviews.

In addition to obtaining extensive experience in private practice, Simon has at different points in his career gained invaluable experience working at both the UK Competition & Markets Authority and the European Commission’s Directorate-General for Competition.

In particular, Simon has considerable experience in managing and coordinating worldwide merger control filings for multi-national transactions, with recent experience of the CMA and EUMR merger control regimes. On the behavioural side, Simon has assisted clients in relation to investigations conducted by UK, EU and US competition law enforcement bodies. In addition, he also regularly advises on UK and EU regulatory matters, public procurement and regulated utilities.

Simon's experience spans a wide range of industries, including fast food franchising, consumer goods, radio advertising, crop protection, financial services, construction equipment, cleaning chemicals, shipping, medical devices and the UK water sector.

Concentrations

  • Competition law
  • Merger control
  • Antitrust litigation
  • Public procurement
  • State aid

Expertise

Erfahrung

 
  • Performing Assistant Legal Director role at the UK Competition & Markets Authority in relation to a number of phase 2 merger inquiries.
  • Acting as global merger control coordinator for Platform Specialty Product’s US$4.2 billion sale of its agricultural solutions business, Arysta LifeScience, to UPL Corporation, including an EUMR clearance and coordination of national filings in Argentina, Brazil, CEMAC, Colombia, COMESA, Costa Rica, Kenya, Mexico, Pakistan, Russia, South Africa, Tanzania, Ukraine and the United States.
  • Advising on the behavioural competition law compliance aspects of the US$4.7 billion acquisition of Sky Betting & Gaming by The Stars Group.
  • Acting for AstraZeneca in relation to the sale of the rights to proton pump inhibitor Nexium in Europe to Grünenthal Group for an upfront payment of $700 million with further sales-related and milestone payments of up to $90 million, including coordination of merger control filings in Austria and Germany.
  • Advising on the merger control and behavioural competition law aspects of Rentokil Initial's joint venture with Haniel & Cie to provide workwear and washroom services in a number of European countries, including obtaining EUMR clearance from the European Commission.
  • Advising on the merger control aspects of AstraZeneca’s sale of the global rights (excluding the US and Japan) to Vimovo to Grünenthal Group for an upfront payment of $115 million and further payments up to another $17 million, including coordination of merger control filings in Austria, Brazil and Germany.
  • Advising a leading construction equipment manufacturer on the behavioural competition law compliance and UK merger control aspects of the disposal of its British dealership.
  • Advising AstraZeneca in relation to the disposal of the rights to migraine treatment Zomig to German pharmaceutical company Grünenthal Group for an upfront payment of $200 million with further sales-related and milestone payments of up to $102 million, involving coordination of merger control filings in Brazil and Germany.
  • Providing advice to a fast food chain on the EU and UK competition law and merger control aspects of its UK joint venture, which acts as master franchisee for the management of the franchise in the UK.
  • Advising Smiths Group on the behavioural competition law and merger control aspects of its US$112.5 million disposal of the Smiths Interconnect’s Microwave Telecoms business to Infinite Electronics Inc., a portfolio company of Genstar Capital.
  • Acting for Navico AS on the merger control aspects of the acquisition of the Jeppesen marine navigation and cartography business from Boeing, including coordination of merger control notifications in Brazil, Cyprus and Russia.
  • Acting as global merger control coordinator for Jarden Corporation in relation to the US$15.4 billion sale of Jarden to Newell Rubbermaid Inc., including an EUMR filing as well as national filings in Argentina, Colombia, Costa Rica, Mexico, Russia, South Korea and the United States.
  • Advised Atlas Mara Limited in relation to the COMESA merger control filing submitted in respect of its acquisition of Finance Bank Zambia plc, a multi-service bank with operations in Zambia.
  • Acted for Nomad Foods Limited in obtaining merger control clearance in Russia for its €2.6 billion acquisition of the Bird's Eye/Iglo group and its subsequent £500 million acquisition of the continental European business of the Findus Group, which required coordination of merger control clearances in Austria, Germany and Spain as well as detailed EU antitrust advice on information exchange issues.
  • Advised IlluminOss Medical, Inc., a US manufacturer of innovative minimally invasive orthopaedic implants, on its distribution strategy in the UK and negotiated an exclusive distribution agreement that resulted in IlluminOss' entry into the UK market.
  • Obtained merger control clearances in Germany and Ukraine in respect of Platform Specialty Products' acquisition of two of OM Group's specialty chemicals divisions for approximately US$367 million.
  • Advised Jarden Corporation on the merger control aspects of its US$1.35 billion acquisition of consumer products manufacturer Waddington Group, Inc.
  • Acted for US client Firetrace in relation to the distribution strategy for its fire extinguisher products, the appointment of distributors and assisted in the negotiation of a distribution arrangement.
  • Advised Foxconn Interconnect Technology Ltd., a subsidiary of Taiwanese conglomerate Hon Hai Precision Industry Co. Ltd., on the merger control aspects of its acquisition of the optical modules business of Avago Technologies Ltd.
  • Coordinated merger control filings for Platform Specialty Products' acquisition of Arysta LifeScience, an agrochemicals company, for approximately US$3.51 billion with clearances obtained in Brazil, COMESA, Kenya, Mexico, Namibia, Poland, Russia, South Africa and Tanzania.
  • Coordinated merger control filings for Atlas Mara Co-Nvest's acquisition of Sub-Saharan African banking group BancABC for approx. US$265 million with filings submitted to the Botswana, COMESA and Tanzania merger control authorities.
  • Provided competition advice concerning a number of franchise arrangements in the convenience food sector in France, Italy, Greece, Poland, Romania and the United Kingdom.
  • Advised a leading manufacturer of construction equipment on the acquisition of a competitor, including the coordination of merger control filings in Australia, China, Colombia, the European Union, Indonesia and South Africa.
  • Provided advice to a provider of third party maintenance services regarding the actions of the supplier of business software aimed at preventing customers from employing independent maintenance businesses.
  • Assisted Bristol Water in relation to an Ofwat-led Competition Act 1998 investigation into the self-lay sector.
  • Assisted Utilita Services Limited in relation to achieving changes to the industry rules regarding the allocation and pricing of wholesale gas.
  • Provided merger control advice to Rentokil Initial on its sale of City Link to Better Capital, a private equity investor.
  • Advised Jarden Corporation in relation to its approximately US$1.8 billion acquisition of Yankee Candle Company and obtaining merger control clearances in Austria and Germany.
  • Provided public procurement advice to a leading provider of third party software maintenance services in relation to its bid to become a supplier to the UK public sector under UK-wide framework agreement.
  • Provided advice to a medical devices manufacturer in relation to challenges to the procurement decisions of UK public authorities.
  • Assisted a sports equipment manufacturer in relation to the European aspects of an ultimately settled investigation by the U.S. Federal Trade Commission into an alleged non-compete agreement covering professional endorsers and employees.
  • Advised Sport Universal Process S.A.S. (Amisco) in relation to obtaining merger control clearance from the UK's Office of Fair Trading in respect of its acquisition of Prozone Sports Limited.
  • Advised AstraZeneca plc on the international merger control aspects of the sale of its dental and health care subsidiary Astra Tech AB to Dentsply International Inc.
  • Advised a U.S. satellite communications company on its applications to the EU's General Court for annulment of separate decisions by the European Council and the European Parliament, and the European Commission under Article 264 of the Treaty on the Functioning of the EU.
  • Advised a UK water utility on the applicability of UK competition law to certain pricing practices in the water industry.

°Certain of the above representations were handled by Mr. Harms prior to his joining Greenberg Traurig, LLP. 

  • Secondee (equivalent to Assistant Legal Director)– Competition & Markets Authority, Legal Service, 2019-2020 
  • Associate - Watson, Farley & Williams LLP, 2008-2010
  • Trainee Solicitor - Watson, Farley & Williams LLP, 2006-2008
  • Stagiaire - European Commission, Directorate-General for Competition, 2004

Anerkennung durch den Markt

  • Listed, Super Lawyers magazine, London Super Lawyers, 2014
  • Member, Law Society of England and Wales
    • Member, Competition Section
  • Member, Law Society of Ireland
  • Member, Competition Law Association
  • Member and Administrator, Competition Pro Bono Scheme

Ausbildung

Akademische Ausbildung
  • M.A., EU Competition Law, King's College London, 2015
  • Postgraduate Diploma, EU Competition Law, King's College London, 2012
  • Legal Practice Course (LPC), University of the West of England, Bristol, 2005
  • LL.B., European Law with Spanish, Coventry University, 2003
Zulassung
  • England & Wales
Sprache
  • Deutsch, Fluent
  • Spanisch, Conversational